Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background . Atherothrombotic disease, including coronary artery disease (CAD) and peripheral artery disease (PAD), can lead to cardiovascular (CV) events, such as myocardial infarction, stroke, limb ischemia, heart failure, and CV death. Aim . Evaluate the humanistic and economic burden of CAD and PAD and identify unmet needs through a comprehensive literature review. Methods . Relevant search terms were applied across online publication databases. Studies published between January 2010 and August 2017 meeting the inclusion/exclusion criteria were selected; guidelines were also included. Two rounds of screening were applied to select studies of relevance. Results . Worldwide data showed approximately 5–8% prevalence of CAD and 10–20% prevalence of PAD, dependent on the study design, average age, gender, and geographical location. Data from the REACH registry indicated that 18–35% of patients with CAD and 46–68% of patients with PAD had disease in one or more vascular beds. Use of medication to control modifiable CV risk factors was variable by country (lower in France than in Canada); statins and aspirin were the most widely used therapies in patients with chronic disease. Survival rates have improved with medical advancements, but there is an additional need to improve the humanistic burden of disease (i.e., associated disability and quality of life). The economic burden of atherothrombotic disease is high and expected to increase with increased survival and the aging population. Conclusion . CAD and PAD represent a substantial humanistic and economic burden worldwide, highlighting a need for new interventions to reduce the incidence of atherothrombotic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Baseline characteristics and medication use and clinical outcomes in patients with CAD and PAD from the REACH Registries of (a) Canada,a (b) France,b and (c) Germanyc [1, 2]. aPatients enrolled from January to October 2004; mean age 68.4 ± 9.9. bPercentage of patients experiencing at least one CV event (Figure (a): CAD n = 1356, PAD n = 146; Figure (b): CAD n = 2397, PAD n = 882; Figure (c): CAD n = 3328, PAD n = 1303). cPatients enrolled from December 2003 to June 2014; mean age 69.1–71.7 across risk groups. dPatients enrolled from December 2003 to June 2014; mean age 68.0–69.4 across risk groups. ACE, angiotensin-converting enzyme; ASA, acetylsalicylic acid; CAD, coronary artery disease; CV, cardiovascular; PAD, peripheral artery disease.](https://figures.cochat.ai/paper-figures/5e14fc8ebda846379e697620627d3268/burden-of-coronary-artery-disease-and-peripheral-artery-disease-a-literature-figure-1.jpg)
![Figure 2 The persistent risk of MACE (a) up to 3 years following an index MI (adapted from Blin et al., 2016) [3] and (b) up to 4.5 years following an index MI stratified by age (<72 years old versus ≥72 years old) and risk category (low versus higha) (adapted from Jernberg et al., 2015) [4]. aHigh-risk patients were predefined as those with ≥1 of the following risk factors prior to index; MI: diabetes mellitus, at least one MI prior to index MI event, CABG (proxy for multi-vessel CAD), PAD, stroke, heart failure, or diagnosis of chronic renal dysfunction. CABG, coronary artery bypass graft; CAD, coronary artery disease; CV, cardiovascular; HR, high risk; LR, low risk; MACE, major adverse cardiovascular events; MI, myocardial infarction; PAD, peripheral artery disease.](https://figures.cochat.ai/paper-figures/ef7f32f05aeb4415a5daae684132145b/burden-of-coronary-artery-disease-and-peripheral-artery-disease-a-literature-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mere presence of PAD significantly increases the risk of having atherosclerotic disease in other vascular beds.”
From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Approximately, 46% to 68% of patients with PAD also had coronary artery disease (CAD) or cerebrovascular disease.[48][49][50]”
From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191 · cited 1×
“These conditions are characterized by progressive (CLI) or sudden onset (ALI) of pain at rest or nonhealing ischemic wounds or gangrene [27, 44, 45] and can ultimately lead to a loss of limbs [46].”
Background2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Aboyans, V., Ricco, J.-B., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J.-P., Czerny, M., De Carlo, M., Debus, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx095 · Cited by 3,293
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Hay, S. I., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32130-x · Cited by 2,083 · cited 1×
“of mortality and morbidity worldwide, atherothrombotic disease places a substantial medical and economic burden on society [7, 12].”
Background2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.007 · Cited by 1,941
Research works printed but not linked: 8
- 2017, Heart and Metabolism, 9
- 2015, La Revue Du Praticien, 65, 317
- 2016, Vascular Medicine (United Kingdom), 21, 331
- 2018, International Angiology, 37, 327
- 2016, JACC: Journal of the American College of Cardiology, 69, e71
- 2016, Circulation: Cardiovascular Quality and Outcomes, 9, 731
- 2013, Health and Quality of Life Outcomes, 11
- 2010, Circulation: Cardiovascular Quality and Outcomes, 3, 642
Cited by
Ralapanawa, U., & Sivakanesan, R. (2021) · Journal of Epidemiology and Global Health · doi:10.2991/jegh.k.201217.001 · Cited by 669
“The risk of dying from CAD rises significantly with aging and systolic blood pressure is the most important modifiable risk factor explaining some additional CAD risks that come about with age [7,16,17].”
Zhou, Y., Zhou, H., Hua, L., Hou, C., Jia, Q., Chen, J., Zhang, S., Wang, Y., He, S., & Jia, E. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.009 · Cited by 249
Mitochondrial Structure and Function in Human Heart Failure
Hinton, A., Claypool, S. M., Neikirk, K., Senoo, N., Wanjalla, C. N., Kirabo, A., & Williams, C. R. (2024) · Circulation Research · doi:10.1161/circresaha.124.323800 · Cited by 220
Wadström, B. N., Wulff, A. B., Pedersen, K. M., Jensen, G. B., & Nordestgaard, B. G. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab705 · Cited by 234
Racial and Ethnic Disparities in Peripheral Artery Disease
Hackler, E. L., Hamburg, N. M., & White Solaru, K. T. (2021) · Circulation Research · doi:10.1161/circresaha.121.318243 · Cited by 141
Kotlyarov, S. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108725 · Cited by 121
“It is widespread and is the main pathophysiological mechanism of coronary heart disease (CHD), carotid artery lesions and ischemic cerebral stroke, as well as peripheral artery disease [12].”
BackgroundOptical coherence tomography angiography of the retina and choroid in systemic diseases
Chua, J., Tan, B., Wong, D. W. K., Garhöfer, G., Liew, X. W., Popa‐Cherecheanu, A., Chin, C. W. L., Miléa, D., Chen, C., & Schmetterer, L. F. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101292 · Cited by 105
ABC transporters: human disease and pharmacotherapeutic potential
Moore, J. M., Bell, E. L., Hughes, R. O., & Garfield, A. S. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.11.001 · Cited by 101
Xu, M., Zhang, L., Xu, D., Shi, W., & Zhang, W. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1485538 · Cited by 80
Kotlyarov, S. N., & Котлярова, А. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031308 · Cited by 69
Role of Vascular Smooth Muscle Cell Phenotype Switching in Arteriogenesis
Ashraf, J. V., & Zen, A. A. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910585 · Cited by 67
“7% of the overall global burden of disease [1].”
BackgroundNew Insights into the Role of Ferroptosis in Cardiovascular Diseases
Pasini, A. M. F., Stranieri, C., Busti, F., Leo, E. G. D., Girelli, D., & Cominacini, L. (2023) · Cells · doi:10.3390/cells12060867 · Cited by 64
“Atherosclerosis underlies the pathophysiology of ischemic heart disease which remains the major cause of death and disability globally [89].”
BackgroundPrediction of Coronary Artery Disease Using Machine Learning Techniques with Iris Analysis
Özbilgin, F., Kurnaz, Ç., & Aydın, E. (2023) · Diagnostics · doi:10.3390/diagnostics13061081 · Cited by 56
“CAD occurs due to the decrease or complete cessation of blood flow to the heart muscle caused by the hardening of these coronary arteries [4,5].”
BackgroundZhang, S., Wang, H., Chen, S., Cai, S., Zhou, S., Wang, C., & Ni, X. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1114053 · Cited by 56
Chronic Limb-Threatening Ischemia and the Need for Revascularization
Berchiolli, R. N., Bertagna, G., Adami, D., Canovaro, F., Torri, L., & Troisi, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072682 · Cited by 54
“The 2010 National Health and Wellness Surveys developed in the USA and Europe reported significant impairment in work in patients with PAD, in particular, absenteeism, presenteeism, overall work productivity loss, and activity impairment [24].”
BackgroundZou, H., Cao, X., & Chair, S. Y. (2021) · Journal of Advanced Nursing · doi:10.1111/jan.14738 · Cited by 56
Statins and Peripheral Arterial Disease: A Narrative Review
Jansen‐Chaparro, S., Lopez-Carmona, M. D., Cobos-Palacios, L., Sanz‐Cánovas, J., Bernal-López, M. R., & Gómez‐Huelgas, R. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.777016 · Cited by 51
“Given the relationship of PAD to age (5, 6), an increase in its prevalence and the costs it generates is expected due to increased survival and progressive population aging (2, 7, 8).”
BackgroundEngineered extracellular vesicles and their mimics in cardiovascular diseases
Lai, J., Huang, C., Guo, Y., & Rao, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.046 · Cited by 49
Deep Learning in Heart Sound Analysis: From Techniques to Clinical Applications
Zhao, Q., Geng, S., Wang, B., Sun, Y., Nie, W., Bai, B., Yu, C., Zhang, F., Tang, G., Zhang, D., et al. (2024) · Health Data Science · doi:10.34133/hds.0182 · Cited by 47
“CAD is a major cause of mortality and morbidity worldwide and substantially burdens the medical system [ 138 ].”
BackgroundXu, J., Cai, F., Geng, C., Wang, Z., & Tang, X. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.621389 · Cited by 46
Vakhshoori, M., Nemati, S., Sabouhi, S., Shakarami, M., Yavari, B., Emami, S. A., Bondariyan, N., & Shafie, D. (2023) · Journal of International Medical Research · doi:10.1177/03000605231204469 · Cited by 45
“9 The inflammatory response plays a significant role in both the initiation and progression of atherosclerotic coronary plaques.”
BackgroundDeng, W., Deng, L., Du, C., Liu, L., Wang, Y., Gu, H., Armstrong, D. G., Mills, J. L., Hochlenert, D., Deng, H., et al. (2025) · Research · doi:10.34133/research.0702 · Cited by 45
Paldán, K., Steinmetz, M., Simanovski, J., Rammos, C., Ullrich, G., Jánosi, R. A., Moebus, S., Rassaf, T., & Lortz, J. (2021) · JMIR mhealth and uhealth · doi:10.2196/24214 · Cited by 44
“Although the survival rates for CAD and PAD have improved worldwide, PAD still comes with a high individual burden regarding the quality of life (QoL) and associated disabilities [2].”
BackgroundShi, H., Li, Y., Dong, C., Si, G., Xu, Y., Peng, M., & Li, Y. (2021) · Helicobacter · doi:10.1111/hel.12865 · Cited by 40
The economic burden of coronary heart disease in mainland China
Mi, Y., Xue, Z., Qu, S., Yin, Y., Huang, J.-W., Kou, R., Wang, X., Luo, S., Li, W., & Tang, Y. (2023) · Public Health · doi:10.1016/j.puhe.2023.08.034 · Cited by 39
Risk factors for fracture-related infection after ankle fracture surgery
Pilskog, K., Høvding, P., Fenstad, A. M., Inderhaug, E., Fevang, J. M., & Dale, H. (2023) · Injury · doi:10.1016/j.injury.2023.111011 · Cited by 38
Shahraki, M. N., Jouabadi, S. M., Bos, D., Stricker, B. H. C., & Ahmadizar, F. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01151-w · Cited by 37
“Coronary artery disease, in particular, is the primary cause of disability-adjusted life years lost globally [3–5], and its risk increases with age [6, 7].”
Background3D‐Printed Radiopaque Bioresorbable Stents to Improve Device Visualization
Ding, Y., Fu, R., Collins, C. P., Yoda, S., Sun, C., & Ameer, G. A. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201955 · Cited by 34
Review on Emerging Therapeutic Strategies for Managing Cardiovascular Disease
Narkhede, M., Pardeshi, A., Bhagat, R., & Dharme, G. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x299265240405080030 · Cited by 40
Diversity of Lipid Function in Atherogenesis: A Focus on Endothelial Mechanobiology
Kotlyarov, S. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111545 · Cited by 37
“Ischemic heart disease, ischaemic stroke, and peripheral arterial disease of the lower extremities are characterized by a wide prevalence and carry a heavy economic and social burden [5,6].”
BackgroundJalali, A., Hassanzadeh, A., Najafi, M. S., Nayebirad, S., Dashtkoohi, M., Karimi, Z., & Shafiee, A. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04896-4 · Cited by 30
“Cardiovascular diseases, particularly coronary artery disease (CAD), are the most prevalent cause of mortality worldwide and represent a major health challenge [1–5].”
BackgroundSong, S., Chen, L., Yu, R., & Zhu, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1442165 · Cited by 30
Dietary Risk Factors and Eating Behaviors in Peripheral Arterial Disease (PAD)
Cecchini, A. L., Biscetti, F., Rando, M. M., Nardella, E., Pecorini, G., Eraso, L. H., DiMuzio, P. J., Gasbarrini, A., Massetti, M., & Flex, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810814 · Cited by 37
“Atherosclerosis is a chronic, progressive disease that affects the main arterial beds including the coronary, carotid and peripheral arterial trees [461].”
BackgroundUrbanowicz, T. K., Michalak, M., Komosa, A., Olasińska‐Wiśniewska, A., Filipiak, K. J., Tykarski, A., & Jemielity, M. (2023) · Cardiology Journal · doi:10.5603/cj.a2023.0033 · Cited by 29
García‐Villén, F., Zárraga, F. L., Viseras, C., Ruíz, S., Khalak, F. A.-H., Diez-Aldama, I., del Burgo, L. S., Scaini, D., & Pedraz, J. L. (2023) · International Journal of Bioprinting · doi:10.18063/ijb.v9i2.664 · Cited by 29
“, “worldwide data showed approximately 5%–8% prevalence of CAD and 10%–20% prevalence of PAD, dependent on the study design, average age, gender, and geographical location”[5].”
BackgroundImproving the Estimation of Coronary Artery Disease by Classification Machine Learning Algorithm
Ghorbani, H., Krasnikova, A., Ghorbani, P., Ghorbani, S., Hovhannisyan, H. S., Minasyan, A., Minasian, N., Alvar, M. A., Stepanyan, H., & Azodinia, M. (2023) · IEEE International Conference and Workshop Óbuda on Electrical and Power Engineering (CANDO-EPE) · doi:10.1109/cando-epe60507.2023.10418014 · Cited by 27
“Numerous elements contribute to the progression of CAD, encompassing Comprehending these factors assists in conducting a comprehensive risk evaluation and implementing focused 2019, the mortality rate associated with coronary artery disease (CAD) was estimated to be around 18.5 million [7 .”
BackgroundInfluentialPeng, H. M., Liu, G., Lian, S., Huang, J., & Zhao, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-93986-3 · Cited by 27
Ferroptosis: a potential therapeutic target in cardio-cerebrovascular diseases
Jiang, C., Yang, Y., Long, T., Xu, J., Chang, C., Kang, M., Wang, X., Chen, Y., & Qiu, J. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05262-7 · Cited by 27
“Atherosclerosis is the foundation of ischemic heart disease, a prevailing global contributor to illness and death [118].”
Liu, H., Jiang, Z.-H., Yang, Z.-B., & Quan, X. (2022) · Medicine · doi:10.1097/md.0000000000030109 · Cited by 27
“Accumulating evidence suggests that coronary heart disease (CHD) is one of the most prevalent and chronic life-threatening disease.[1,2] Patients of CHD are frequently hospitalized and at high risk for death and major adverse cardiac events (MACEs), which would increase the medical burden.”
BackgroundMichael, A. E., Schoenbeck, D., Becker-Assmann, J., Niehoff, J. H., Flohr, T. G., Schmidt, B. T., Panknin, C., Baer‐Beck, M., Hickethier, T., Maintz, D. C., et al. (2023) · European Journal of Radiology · doi:10.1016/j.ejrad.2023.110983 · Cited by 28
Chen, X., Yang, J., Liu, X., He, Y., Luo, Q., Chen, M., & Hu, W. (2025) · Computer Methods in Applied Mechanics and Engineering · doi:10.1016/j.cma.2025.117851 · Cited by 26
Liu, Q., Wu, H., Yu, Z., Huang, Q., & Zhong, Z. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23925 · Cited by 27
Lin, D. S., Lo, H.-Y., Yu, A., Lee, J., & Chien, K. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01143-x · Cited by 26
“Patients with PAD often have concurrent atherosclerotic disease in multiple vascular beds [2], placing this population at high risk for cardiovascular morbidity and mortality.”
BackgroundWang, Y., Qiu, X., Wei, Y., & Schwartz, J. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029428 · Cited by 27
Chen, Y., Zhou, Z.-F., Han, J.-M., Jin, X., Dong, Z., Liu, L., Wang, D., Ye, T., Yang, B., Zhang, Y., et al. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-2766 · Cited by 25
Maas, D. P. M. S. M., Willems, L. H., Kranendonk, J., Kramers, C., & Warlé, M. C. (2024) · Drugs · doi:10.1007/s40265-024-02076-7 · Cited by 25
Huseynov, A., Reinhardt, J., Chandra, L., Dürschmied, D., & Langer, H. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076280 · Cited by 26
“Together, CAD and PAD represent a significant medical and economic burden worldwide, which can be improved through better use of guidelines, modification of risk factors and drug or non-drug interventions [49].”
BackgroundZhang, Z., Chi, J. A., Driskill, E. K., Mont, M. A., Jones, L. C., & Cui, Q. (2023) · The Journal of Arthroplasty · doi:10.1016/j.arth.2023.12.029 · Cited by 24
PFAS and their association with the increased risk of cardiovascular disease in postmenopausal women
Eve, A. A., Tunc, E. P., Mehta, D., Yoo, J. Y., Yılmaz, H. E., Emren, S. V., Akçay, F. A., & Madak‐Erdogan, Z. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae065 · Cited by 25
Yang, R., Zhang, X., Xing, P., Zhang, S., Zhang, F., Wang, J., Yu, J., Zhu, X., & Chang, P. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.014 · Cited by 23
Hypertension and Cardiovascular Diseases among Electronic and Combustible Cigarette Users
Falk, G. E., Okut, H., Vindhyal, M. R., & Ablah, E. A. (2022) · Kansas Journal of Medicine · doi:10.17161/kjm.vol15.16752 · Cited by 23
Complex and high-risk intervention in indicated patients (CHIP) in contemporary clinical practice
Fujimoto, Y., Sakakura, K., & Fujita, H. (2023) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-023-00930-1 · Cited by 23
“As the proportion of the elderly and the prevalence of lifestyle diseases continue to grow, the number of patients with CAD has been increasing in most countries [4, 5].”
BackgroundNET-(works) in arterial and venous thrombo-occlusive diseases
Zdanytė, M., Borst, O., & Münzer, P. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1155512 · Cited by 23
Chen, W., Li, B., Wang, H., Wei, G., Chen, K., Wang, W., Wang, S., & Liu, Y. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03831-0 · Cited by 23
“CAD is one of the diseases that seriously affect human health at present, and its morbidity and mortality are on the rise in recent years [4, 5].”
BackgroundHe, F., Andrabi, S. M., Shi, H., Son, Y., Qiu, H., Xie, J., & Zhu, W. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.12.009 · Cited by 23
Zhao, P., Wang, Y., Zhang, L., Zhang, J., Liu, N., & Wang, H. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4838 · Cited by 23
“miR‐532‐3p is involved in atherothrombotic events that may lead to HF (19,20).”
Diabetes mellitus: Complications, emerging therapeutic targets, and evolving treatment approaches
Mohd, S., Kumar, L. L., Harish, V., Kumar, R., Chaudhary, A., & Sharma, V. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100652 · Cited by 28
RhoA/ROCK-1 Signaling Pathway and Oxidative Stress in Coronary Artery Disease Patients
Dokumacıoğlu, E., Düzcan, I., İskender, H., & Şahin, A. (2021) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2020-0525 · Cited by 21
“Although atherosclerosis is the primary factor causing CAD, many other reasons such as coronary vasospasm, coronary artery embolism, coronary artery anomalies, vasculitis, rheumatic diseases, and trauma can also lead to CAD[3].”
BackgroundZhou, M., Wu, J., & Tan, G. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02836-4 · Cited by 29
Fan, Z., Yang, C., Li, Y., Yang, J. M., & huang, C. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11734 · Cited by 22
Tapos, G.-F., Cîmpeanu, I.-A., Predescu, I.-A., Liga, S., Păcurar, A. T., Vlad, D. C., Boru, C., Luca, S. A., Crișan, S., Văcărescu, C., et al. (2026) · Diseases · doi:10.3390/diseases14010031 · Cited by 21
“According to the Global Burden of Disease study, in 2019 there were over 56 million PAD cases among adults aged 40–70 years, and 57 million cases in those over 70 [51].”
Arnholdt, C., Kumaraswami, K., Götz, P., Kübler, M., Lasch, M., & Deindl, E. (2022) · Cells · doi:10.3390/cells11091490 · Cited by 20
“Despite some improvements in the prevention and treatment of CHD and PAD, these diseases still represent a substantial medical burden worldwide [4].”
BackgroundPuchałowicz, K., Kłoda, K., Dziedziejko, V., Rać, M. E., Wojtarowicz, A., Chlubek, D., & Safranow, K. (2021) · Diagnostics · doi:10.3390/diagnostics11101774 · Cited by 20
“Coronary artery disease (CAD) is the leading global problem of public health because it is related to high morbidity and mortality and is a large burden for financial and health systems [1].”
BackgroundBerkowitz, S. D., Bauersachs, R. M., Szarek, M. J., Nehler, M. R., Debus, E. S., Patel, M. R., Anand, S. S., Capell, W. H., Hess, C. N., Hsia, J. A., et al. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15673 · Cited by 20
Self-citationZhou, H., Gan, X., He, S., Wang, Y., Zhang, S., Chen, J., Zhou, Y., Hou, C., Hua, L., Zhang, Q., et al. (2022) · Clinical Proteomics · doi:10.1186/s12014-022-09374-w · Cited by 19
“Background Coronary artery disease (CAD) is still the most prominent cause of mortality globally, and it leads to a substantial medical and economic burden worldwide [1].”
BackgroundLess Is More: Developments in Nanotechnology for Antirestenosis Therapies
Trepanier, C. M., Burke‐Kleinman, J., Strauss, B. H., Santerre, J. P., & Bendeck, M. P. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.318450 · Cited by 19
Liu, D., Xu, W., Xu, H., Zhao, L., & Jin, D. Q. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1265983 · Cited by 19
Barbălată, T., Moraru, O. E., Stancu, C. S., Devaux, Y., Simionescu, M., Sima, A. V., & Niculescu, L. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249600 · Cited by 19
“Peripheral artery disease (PAD) is an atherosclerotic disorder that affects arteries in the lower limbs and is one of the main causes of mortality and morbidity worldwide [4].”
BackgroundDirect Oral Anticoagulants and Coronary Artery Disease
Choxi, R., Kapoor, K., Mackman, N., & Jovin, I. S. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.317171 · Cited by 19
Mediterranean diet and health – a narrative review
Shriqui, V. K., Navarro, D. A., Salem, H., & Boaz, M. (2022) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v12i9.989 · Cited by 22
Huo, Y., Feng, Q., Fan, J., Huang, J., Zhu, Y., Wu, Y., Hou, A., & Zhu, L. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24803 · Cited by 18
Wen, G., Shan, Y., Chen, J., & Zhou, S. (2023) · Galen Medical Journal · doi:10.31661/gmj.v12i.2994 · Cited by 18
“C oronary heart disease (CHD) is a prevalent and life-threatening condition that requires diligent nursing care [1, 2].”
Huo, Y., Lai, Y., Feng, Q., Wang, Q., & Li, J. (2022) · Biomarkers in Medicine · doi:10.2217/bmm-2022-0673 · Cited by 20
Zhang, Z., Qian, H., Wang, L., Tao, Z., Cheng, K., Wang, K., Xie, Y., & Zhang, L. (2022) · Cardiology Research and Practice · doi:10.1155/2022/4017082 · Cited by 17
Wang, J., Xiao, Q., Cai, Y., Wang, M., Chen, C., Wang, L., Ma, R., Cao, Y., Wang, Y., Ding, H., et al. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.08.005 · Cited by 19
Morrison, A. M., & Aday, A. W. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.02.021 · Cited by 17
Recent Advances in Association Between Vitamin D Levels and Cardiovascular Disorders
Agarwal, P., Agarwal, Y., & Hameed, M. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01246-4 · Cited by 16
Grave, C., Bonaldi, C., Carcaillon‐Bentata, L., Gabet, A., Halimi, J., Tzourio, C., Béjot, Y., Torres, M. J., Steg, P. G., Durand‐Zaleski, I., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23760 · Cited by 17
Ware, H. O. T., Ding, Y., Collins, C. P., Akar, B., Akbari, N., Wang, H., Duan, C., Ameer, G. A., & Sun, C. (2022) · Materials Today Chemistry · doi:10.1016/j.mtchem.2022.101231 · Cited by 16
Carlsson, K. S., Faurby, M. D., Nilsson, K., & Wolden, M. L. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01430-4 · Cited by 15
Coassy, A., Svedbom, A., Locrelle, H., Chapurlat, R. D., Cortet, B., Fardellone, P., Orcel, P., Roux, C., Borgström, F., Kanis, J. А., et al. (2021) · Osteoporosis International · doi:10.1007/s00198-021-06189-7 · Cited by 15
Quality Analysis of Online Resources for Patients with Peripheral Artery Disease
Treffalls, J. A., Treffalls, R. N., Zachary, H., Clothier, W., Tolbert, P. H., Yan, Q., & Davies, M. G. (2022) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2021.12.079 · Cited by 15
Li, H.-R., Zheng, X.-M., Liu, Y., Tian, J.-H., Kou, J., Shi, J.-Z., Pang, X., Xie, X., & Yu, Y. (2022) · Cardiovascular Therapeutics · doi:10.1155/2022/9615674 · Cited by 16
“In fact, previous clinical studies have suggested that LC supplementation can reduce the mortality of myocardial infarction, but the specific mechanism of action is still unclear, and the effect of LC on the apoptosis pathway is still under investigation [4, 25].”
BackgroundHuang, S., Yang, S., Ly, S., Yoo, R. H., Lo‐Ciganic, W., Eadon, M. T., Schleyer, T., Whipple, E. C., & Nguyen, K. A. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-022-03346-7 · Cited by 15
“Peripheral artery disease (PAD) affects up to 20% of individuals worldwide [1].”
BackgroundFluid-structure interactions of peripheral arteries using a coupled in silico and in vitro approach
Schoenborn, S., Lorenz, T., Kuo, K., Fletcher, D. F., Woodruff, M. A., Pirola, S., & Allenby, M. C. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107474 · Cited by 15
Xia, J., Chen, J., Xing, X., Meng, J., Song, X., & Lou, D. (2024) · Drug Development Research · doi:10.1002/ddr.22152 · Cited by 14
Liu, M., Xu, Z., Wang, Z., Wang, D., Yang, M., Li, H., Zhang, W., He, R., Cheng, H., Guo, P., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1380727 · Cited by 14
“Coronary artery disease (CAD) is a global epidemic disease that has been identified as the major cause of death in both industrialized and developing countries (1–3).”
BackgroundJeong, Y., Choi, B., 김석재, Jo, J., Shanmugasundaram, A., Kang, S., Kim, H., Choi, E., & Lee, D. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.152851 · Cited by 14
Mindfulness therapy for patients with coronary heart disease: A systematic review and meta‐analysis
Li, W., Liao, X., Geng, D., Yang, J., Chen, H., Hu, S., & Dai, M. (2024) · International Journal of Nursing Practice · doi:10.1111/ijn.13276 · Cited by 14
Colombo, A., Chiastra, C., Gallo, D., Loh, P. H., Dokos, S., Zhang, M., Keramati, H., Carbonaro, D., Migliavacca, F., Ray, T., et al. (2025) · International Journal for Numerical Methods in Biomedical Engineering · doi:10.1002/cnm.70000 · Cited by 14
Mu, L., Zou, Y., Tang, J. T., Zhang, F., Chen, D., Lisha, M., Xu, H., Yu, P., Ren, Y., & Mei, Y. (2023) · Nutrición Hospitalaria · doi:10.20960/nh.04622 · Cited by 13
Lin, D. S., Huang, K., Lin, T., Lee, J., & Lin, L. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.05.004 · Cited by 13
Özbeyaz, N. B., Gökalp, G., Algül, E., Şahan, H. F., Aydınyılmaz, F., Gulıyev, İ., Kalkan, K., & Pamukçu, H. E. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02788-2 · Cited by 13
“All these risk factors are also found in coronary artery disease (CAD), that develops with almost the exact physio-pathological mechanisms, and PAD and CAD are often seen together [3].”
BackgroundAcetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease
Cortellini, G., Raiteri, A., Galli, M., Lotrionte, M., Piscaglia, F., & Romano, A. G. (2023) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-023-02782-1 · Cited by 13
“ASCVD can lead to cardiovascular events, such as myocardial infarction, heart failure, stroke, limb ischemia, and cardiovascular death [2].”
BackgroundSoni, P., Kumar, S., Kumar, B., Rai, S. K., Verma, A. K., & Shankar, O. (2024) · Journal of the Brazilian Society of Mechanical Sciences and Engineering · doi:10.1007/s40430-024-04875-1 · Cited by 14
“Coronary artery disease worldwide data, the prevalence of CAD is between 5 and 8%, and that of PAD is between 10 and 20% among people, depending on age group, gender distribution, and region [5].”
Oflar, E., Akdeniz, E., Yıldız, C., Koyuncu, A., Mavi, B., Karabulut, D., Çağlar, F. N. T., Kavala, A. A., & Türkyılmaz, S. (2024) · Vascular · doi:10.1177/17085381241251772 · Cited by 13
“2,20 In recent years, the contribution of in fl ammatory processes in the development of atherosclerosis have been emerged with compelling evidence.”
Jarosinski, M. C., Hafeez, M. S., Sridharan, N. D., Andraska, E., Meyer, J., Khamzina, Y., Tzeng, E., & Reitz, K. M. (2024) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2024.08.033 · Cited by 13
Michael, A. E., Schoenbeck, D., Woeltjen, M. M., Boriesosdick, J., Niehoff, J. H., Surov, A., Borggrefe, J., Schmidt, B. T., Panknin, C., Hickethier, T., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27636 · Cited by 12
“In the longitudinal reconstruction, the first ROI [1] was set in the contrast-filled tube outside the stent, the second ROI [2] within the visible stent lumen prior to the stenosis, ROI [3] within the plaque and ROI [4] within the surrounding saline.”
BackgroundMethodPolydiolcitrate–MoS2 Composite for 3D Printing Radio-Opaque, Bioresorbable Vascular Scaffolds
Szydłowska, B. M., Ding, Y., Moore, C., Cai, Z., Torres‐Castanedo, C. G., Collins, C. P., Jones, E. C., Hersam, M. C., Sun, C., & Ameer, G. A. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c07364 · Cited by 12
Nejim, B. J., Snow, R., Chau, M. H., Sakya, S. M., Ramirez, M. C. C., Flohr, T. R., Brehm, C., & Aziz, F. (2024) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2024.11.002 · Cited by 12
Metadata
- Authors
- Bauersachs, R., Zeymer, U., Brière, J.-B., Marre, C., Bowrin, K., & Huelsebeck, M.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Klinikum Ludwigshafen (DE)
- Bayer (Germany) (DE)
- Creativ-Ceutical (France) (FR)
- Bayer (United Kingdom) (GB)
- Corresponding author
- Bauersachs, Rupert
- Venue
- Cardiovascular Therapeutics
- Publisher
- Wiley
- Published
- 2019-11-26
- Volume
- 2019
- Pages
- 1-9
- ISSN
- 1755-5914 (ISSN-L)
- 1755-5922
- PMC
- PMC7024142
- OpenAlex
- W2990657953
- Semantic Scholar
- 7306e92becdce616c64c569876ca723660f04cb3
- Cited by
- 449
- References
- 52
- Citations by year
- 2026: 39 · 2025: 80 · 2024: 118 · 2023: 102 · 2022: 64 · 2021: 38 · 2020: 8
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Cardiovascular Therapeutics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by)
- Funders
- Bayer AG
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Keywords
- coronary artery disease, peripheral arterial disease, atherothrombosis, disease burden, economic burden, humanistic burden, prevalence, quality of life, disability, statins, aspirin, cardiovascular risk management, survival rate, population aging, unmet needs
- MeSH terms
- Aged, Coronary Artery Disease, Female, Health Services Needs and Demand, Humans, Male, Prognosis, Risk Factors, Global Health, Incidence, Prevalence, Health Care Costs, Cost of Illness, Peripheral Arterial Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.